Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies.
de Witte MA, Janssen A, Nijssen K, Karaiskaki F, Swanenberg L, van Rhenen A, Admiraal R, van der Wagen L, Minnema MC, Petersen E, Raymakers RAP, Westinga K, Straetemans T, Halkes CJM, Boelens JJ, Kuball J. de Witte MA, et al. Among authors: westinga k. Blood Adv. 2021 Jan 12;5(1):240-249. doi: 10.1182/bloodadvances.2020002444. Blood Adv. 2021. PMID: 33570642 Free PMC article. Clinical Trial.
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells.
Te Boome LC, Mansilla C, van der Wagen LE, Lindemans CA, Petersen EJ, Spierings E, Thus KA, Westinga K, Plantinga M, Bierings M, Broers AE, Cuijpers ML, van Imhoff GW, Janssen JJ, Huisman C, Zeerleder S, Huls G, Boelens JJ, Wulffraat NM, Slaper-Cortenbach IC, Kuball J. Te Boome LC, et al. Among authors: westinga k. Leukemia. 2015 Sep;29(9):1839-46. doi: 10.1038/leu.2015.89. Epub 2015 Apr 3. Leukemia. 2015. PMID: 25836589 Clinical Trial.
Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients.
Oostvogels R, Kneppers E, Minnema MC, Doorn RC, Franssen LE, Aarts T, Emmelot ME, Spierings E, Slaper-Cortenbach I, Westinga K, Goulmy E, Lokhorst HM, Mutis T. Oostvogels R, et al. Among authors: westinga k. Bone Marrow Transplant. 2017 Feb;52(2):228-237. doi: 10.1038/bmt.2016.250. Epub 2016 Nov 14. Bone Marrow Transplant. 2017. PMID: 27841858 Clinical Trial.
Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile.
van der Wagen LE, Miranda-Bedate A, Janssen A, Fernando F, Appukudige N, van Dooremalen S, Westinga K, Admiraal R, Lorenowicz MJ, Huls G, Janssen JJWM, Broers AEC, van der Velden WJFM, van Marwijk Kooy R, Hazenberg MD, de Haar C, Lindemans C, Jan Boelens J, Kuball J. van der Wagen LE, et al. Among authors: westinga k. Bone Marrow Transplant. 2020 Nov;55(11):2188-2192. doi: 10.1038/s41409-020-0910-9. Epub 2020 Apr 28. Bone Marrow Transplant. 2020. PMID: 32346077 No abstract available.
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients.
Bethge WA, Eyrich M, Mielke S, Meisel R, Niederwieser D, Schlegel PG, Schulz A, Greil J, Bunjes D, Brecht A, Kuball J, Schumm M, Vucinic V, Wiesneth M, Bonig H, Westinga K, Biedermann S, Holtkamp S, Karitzky S, Malchow M, Siewert C, Handgretinger R, Lang P. Bethge WA, et al. Among authors: westinga k. Bone Marrow Transplant. 2022 Mar;57(3):423-430. doi: 10.1038/s41409-021-01551-z. Epub 2021 Dec 24. Bone Marrow Transplant. 2022. PMID: 34952929 Free PMC article. Clinical Trial.
Graft engineering: how long can you wait, how low can you go, and pandemic readiness.
Nijssen K, Westinga K, Stuut A, Janssen A, van Rhenen A, van der Wagen L, Daenen LGM, Oostvogels R, de Witte MA, Kuball J. Nijssen K, et al. Among authors: westinga k. Bone Marrow Transplant. 2023 Jul;58(7):820-822. doi: 10.1038/s41409-023-01976-8. Epub 2023 Apr 3. Bone Marrow Transplant. 2023. PMID: 37012417 Free PMC article. No abstract available.
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma.
Franssen LE, Roeven MWH, Hobo W, Doorn R, Oostvogels R, Falkenburg JHF, van de Donk NW, Kester MGD, Fredrix H, Westinga K, Slaper-Cortenbach I, Spierings E, Kersten MJ, Dolstra H, Mutis T, Schaap N, Lokhorst HM. Franssen LE, et al. Among authors: westinga k. Bone Marrow Transplant. 2017 Oct;52(10):1378-1383. doi: 10.1038/bmt.2017.118. Epub 2017 Jun 5. Bone Marrow Transplant. 2017. PMID: 28581468 Clinical Trial.
Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa.
Rashidghamat E, Kadiyirire T, Ayis S, Petrof G, Liu L, Pullabhatla V, Ainali C, Guy A, Aristodemou S, McMillan JR, Ozoemena L, Mee J, Pramanik R, Saxena A, Nuamah R, de Rinaldis E, Serrano S, Maurin C, Martinez-Queipo M, Lwin SM, Ilic D, Martinez A, Dazzi F, Slaper-Cortenbach I, Westinga K, Zeddies S, van den Broek M, Onoufriadis A, Mellerio JE, McGrath JA. Rashidghamat E, et al. Among authors: westinga k. J Am Acad Dermatol. 2020 Aug;83(2):447-454. doi: 10.1016/j.jaad.2019.11.038. Epub 2019 Nov 28. J Am Acad Dermatol. 2020. PMID: 31786163 Free article. Clinical Trial.
Intramyocardial bone marrow cell injection does not lead to functional improvement in patients with chronic ischaemic heart failure without considerable ischaemia.
Mann I, Tseng CCS, Rodrigo SF, Koudstaal S, van Ramshorst J, Beeres SL, Dibbets-Schneider P, de Geus-Oei LF, Lamb HJ, Wolterbeek R, Zwaginga JJ, Fibbe WE, Westinga K, Bax JJ, Doevendans PA, Schalij MJ, Chamuleau SAJ, Atsma DE. Mann I, et al. Among authors: westinga k. Neth Heart J. 2019 Feb;27(2):81-92. doi: 10.1007/s12471-018-1213-2. Neth Heart J. 2019. PMID: 30569306 Free PMC article.
11 results